5 evolution "https:" "https:" "https:" "https:" "https:" "https:" "The University of Edinburgh" positions at Center for Biologics Evaluation and Research (CBER)

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 4 days ago

*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available in the Division of Plasma Protein Therapeutics (DPPT), Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA) in Silver Spring, Maryland. The...

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 3 days ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Data Science Fellowship - Bioinformatics and AI/Machine Learning

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 14 hours ago

products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Research Project: The fellow will contribute to the development of novel scientific, bioinformatics, and AI/machine

FDA Fellowship - Malaria Parasite Gene Regulation

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 1 day ago

various stages of parasite development. This is a pioneering project that seeks to define the global post-transcriptional regulatory processes involved in parasite transmission. The results of these studies

FDA Optimization Modeling to Support Benefit-Risk Assessment Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 3 days ago

products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Research Project: You will participate in the development of novel quantitative approaches for benefit-risk analyses